CAN ARTIFICIAL INTELLIGENCE HELP US CURE DIABETES?

Claudia Carletti, ricercatrice IRCCS Burlo Garofolo

Marco Marigliano, docente di Pediatria Università di Verona, pediatra Azienda Ospedaliera Universitaria Integrata di Verona

Enza Mozzillo, docente di Pediatria Università Federico II di Napoli, responsabile Centro regionale di diabetologia pediatrica Azienda Ospedaliera Universitaria Federico II di Napoli

Gianluca Tornese, docente di Pediatria Università di Trieste, pediatra IRCCS Burlo Garofolo

Artificial intelligence (AI) is revolutionizing the diagnosis and treatment of many diseases. A prime example is Type 1 diabetes, the most common endocrine-metabolic disease in children, where AI and new technologies are proving essential in improving glycemic control and the quality of life for those affected. This conference will highlight the advances made in the management and prevention of diabetes, from the discovery of insulin to the use of apps, sensors, and insulin pumps, culminating in the development of the artificial pancreas.